Modern approaches to the use of standard samples for various tasks of Russian enterprises can be conditionally divided into two groups: traditional (using CRMs of European (EP), American (USP) and other generally recognized pharmacopoeias) and alternative (created by manufacturing enterprises, companies of the Russian Federation and EAEU countries). In this article we will pay attention to the alternative approach to primary pharmaceutical standards, both for the main substances and for impurities.